Novo Nordisk
NVO
#27
Rank
A$521.22 B
Marketcap
$116.47
Share price
-2.30%
Change (1 day)
-40.99%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): A$28.79 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are A$41.89 Billion. , an increase over its 2023 earnings that were of A$24.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 A$29.97 B22.75%
2023 A$24.41 B57.64%
2022 A$15.48 B5.35%
2021 A$14.70 B12.47%
2020 A$13.07 B13.07%
2019 A$11.56 B-3.35%
2018 A$11.96 B1.79%
2017 A$11.75 B4.52%
2016 A$11.24 B9.42%
2015 A$10.27 B8.24%
2014 A$9.49 B3.45%
2013 A$9.17 B19.02%
2012 A$7.71 B15.21%
2011 A$6.69 B17.71%
2010 A$5.68 B24.78%
2009 A$4.55 B10.62%
2008 A$4.11 B55.97%
2007 A$2.64 B7.07%
2006 A$2.46 B18.18%
2005 A$2.08 B11.33%
2004 A$1.87 B
2002 A$1.20 B-14.39%
2001 A$1.40 B-52.82%
2000 A$2.98 B250%
1999 A$0.85 B31.21%
1998 A$0.64 B34.31%
1997 A$0.48 B11.46%
1996 A$0.43 B9.03%
1995 A$0.39 B-3.15%
1994 A$0.41 B-0.67%
1993 A$0.41 B45.38%
1992 A$0.28 B-13.81%
1991 A$0.32 B37.12%
1990 A$0.24 B-0.79%
1989 A$0.24 B26.2%
1988 A$0.19 B24.97%
1987 A$0.15 B-0.9%
1986 A$0.15 B-7.78%
1985 A$0.16 B24.87%
1984 A$0.13 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$17.58 B-41.33%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.06 B-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.26 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.56 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France